This is a discussion on FDA update on brand drugs for March 11, 2009 within the New Brand Drug Approvals by Month forum, part of the New Drug Approvals and Pipeline category; Expanded indications: PegIntron (pegylated interferon alfa-2b) and Rebetol (ribavirin) by Schering Plough Expanded indication: combination therapy for treating chronic ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
Expanded indications:
PegIntron (pegylated interferon alfa-2b) and Rebetol (ribavirin) by Schering Plough Expanded indication: combination therapy for treating chronic hepatitis C in patients 3 years of age and older with compensated liver disease; first pegylated combination therapy not restricted to treatment-naive patients • Link to Schering Plough press release 3/09 Sources: U.S. Food and Drug Administration. Drugs@FDA. Available at: Drugs@FDA U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. Available at: CBER |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA update on generic drugs for March 11, 2009 | chantell.reagan | New Generic Approvals by Month | 0 | 03-12-2009 01:57 PM |
| FDA update on generic drugs for March 4, 2009 | chantell.reagan | New Generic Approvals by Month | 0 | 03-05-2009 11:49 AM |
| FDA update on brand drugs for March 4, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 03-05-2009 11:20 AM |
| FDA update on brand drugs for February 4, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 02-05-2009 09:43 AM |
| FDA update on brand drugs for January 21, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 01-22-2009 09:55 AM |